Skip to main content

Table 1 Staining results of each samples

From: Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

  ER PgR Ki67 BRCA1 AR IGF1Rb P13K AKT pAKT TUNEL HER2 Fas TGFßR1 GF1Rb
Patient nuc nuc nuc nuc cyto nuc cyto cyto nuc cyto nuc cyto nuc cyto m m m m m
1 pre 158 8 10 121 0 94 0 80 0 46 18 95 5 90 25 1 0 0 3
post 120 10 10 106 95 5 60 70 0 56 0 90 5 0 0 1 10 1 1
2 pre 156 0 20 97 0 124 50 80 0 106 10 42 0 0 0 1 0 2 1
post 110 137 40 4 0 3 0 0 0 109 46 85 0 0 9 1 0 1 3
3 pre 140 6 20 55 0 111 0 90 0 100 105 0 0 40 6 1 0 1 3
post 0 30 50 39 0 5 0 100 0 100 31 0 133 90 6 3 0 1 1
4 pre 156 17 10 116 0 106 0 0 0 88 40 90 0 0 0 1 0 0 1
during 11 203 20 122 0 18 95 0 0 100 85 100 0 0 0 1 0 0 2
post 10 122 30 100 100 15 98 0 0 100 95 95 0 0 3 0 0 1 2
5 pre 172 0 5 100 0 128 0 0 0 15 0 95 16 90 2 2 0 2 1
pre 198 0 3 100 0 109 0 70 0 100 10 80 5 0 0 1 0 1 1
pre 117 0 20 101 0 88 0 0 0 100 90 90 0 24 9 1 0 1 1
pre 162 0 15 98 0 112 0 85 0 100 70 90 0 0 3 1 0 1 1
pre 203 0 10 98 0 120 0 20 0 80 50 80 0 15 0 1   1 1
during 89 141 5 45 0 101 100 90 0 95 19 60 0 0 0 2 0 1 1
post 103 0 20 98 98 100 98 0 0 100 19 95 0 95 0 2 0 1 1
6 pre 205 161 10 80 0 200 90 100 0 98 50 90 46 0 6 1 0 1 3
during 104 170 5 5 0 107 99 0 0 100 3 90 0 0 6 1 0 1 1
  1. Nuclear and cytosolic staining were evaluated by HistoScore. Membrance staining was clasiffied as 0, 1+, 2+ and 3+ following the recommendations for Her2 staining.
  2. nuc: nuclear, cyto: cytosol, m: membrane.